More importantly, our recent study has demonstrated it can mitigate pulmonary artery hypertension with attenuation of right ventricle hypertrophy by suppressing endothelin-1 (ET-1), inactivating RhoA/ROCK, and enhancing eNOS expression [15]. Here, EDN1 is linked to pulmonary arterial hypertension.